Peer-influenced content. Sources you trust. No registration required. This is HCN.


Annals of Internal Medicine

Gabapentinoids and Risk for Severe Exacerbation in Chronic Obstructive Pulmonary Disease

Internal Medicine January 24th 2024

ACP Internist

MKSAP Quiz: Evaluation for Dyspnea

Allergy & Immunology September 7th 2023

Annals of Internal Medicine

Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone–Salmeterol to Treat Chronic Obstructive Pulmonary Disease

Clinical Pharmacology August 31st 2023

The New England Journal of Medicine

Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts

Allergy & Immunology July 27th 2023

COPD News Today

Oxygen Manifesto, Part 1: Advice from 3 Respiratory Specialists

Family Medicine/General Practice May 24th 2023

Journal of Pharmacy Practice (JPP)

Outcomes of a Pharmacy-Driven Inpatient Chronic Obstructive Pulmonary Disease (COPD) Transitions of Care (TOC) Management Process

Clinical Pharmacology April 27th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form